In the recent past, the questions that face a comprehensive psychosomatic medicine have been defined. These questions refer to the context in which disease begins, the timing of the onset of the disease, the role of previous social experience in predisposing to disease, and the choice of the particular disease. It is suggested that a study of bereavement may be paradigmatic in answering these four questions: Bereavement has been cited as a factor in a large variety of disease. However, bereavement may produce discriminated responses of grief; helplessness, hopelessness, and giving-up; and pathological mourning. Pathological mourning in turn may be associated with autoimmune disease. There is evidence that separation and bereavement produces changes in immune function but there is as yet no evidence that it produces distortions of the immune process. There are many factors that affect the timing of disease onset, including maturational ones. Many social experiences have been shown to alter behavior and bodily function and predispose to disease. The question of the choice of disease is determined not only by the effects of bereavement and early experiences, and age, but also by a multiplicity of predisposing ones some of which have been specified.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.